During the visit to Ukraine, local experts met with representatives of more than 23 Indian pharmaceutical and Ayurvedic companies. The purpose of the event was exchanging business opportunities, statistics and discussing bilateral trade in the pharmaceutical sector. The business seminar in Kyiv was attended by representatives of leading Indian pharmaceutical companies and honored guests: representatives of state health authorities of Ukraine, international organizations, profile organizations, and representatives of domestic pharmaceutical business.
«During the last decade (2008-2017), the US Food and Drug Administration approved 5020 Drug Registration Applications under the abridged procedure, of which Indian pharmaceutical companies received approvals for 1,695 applications - almost 34%. At the same time, the USFDA approved 846 Drug Registration Applications under the abridged procedure for 2017, the largest number in a decade. Indian pharmaceutical companies have received 304 approvals, which is about 36% of the total approvals by the USFDA,» - noted Raghuveer Kini, Executive Director of PHARMEXCIL.
Photos provided by Indian Pharmaceutical Manufacturers Organisation.